Annual Accounts Receivable
$28.07 M
+$2.21 M+8.56%
December 31, 2023
Summary
- As of February 7, 2025, ENFN annual accounts receivable is $28.07 million, with the most recent change of +$2.21 million (+8.56%) on December 31, 2023.
- During the last 3 years, ENFN annual accounts receivable has risen by +$15.89 million (+130.45%).
- ENFN annual accounts receivable is now at all-time high.
Performance
ENFN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$32.17 M
-$1.50 M-4.45%
September 30, 2024
Summary
- As of February 7, 2025, ENFN quarterly accounts receivable is $32.17 million, with the most recent change of -$1.50 million (-4.45%) on September 30, 2024.
- Over the past year, ENFN quarterly accounts receivable has increased by +$7.32 million (+29.44%).
- ENFN quarterly accounts receivable is now -4.45% below its all-time high of $33.67 million, reached on June 30, 2024.
Performance
ENFN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ENFN Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.6% | +29.4% |
| 3 y3 years | +130.4% | +29.4% |
| 5 y5 years | +212.8% | +29.4% |
ENFN Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.0% | -4.5% | +76.5% |
| 5 y | 5-year | at high | +212.8% | -4.5% | +164.2% |
| alltime | all time | at high | +212.8% | -4.5% | +164.2% |
Enfusion Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.17 M(-4.5%) |
| Jun 2024 | - | $33.67 M(+8.9%) |
| Mar 2024 | - | $30.93 M(+10.2%) |
| Dec 2023 | $28.07 M(+8.6%) | $28.07 M(+12.9%) |
| Sep 2023 | - | $24.86 M(-1.3%) |
| Jun 2023 | - | $25.17 M(+3.3%) |
| Mar 2023 | - | $24.36 M(-5.8%) |
| Dec 2022 | $25.86 M | $25.86 M(-10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $28.99 M(+0.8%) |
| Jun 2022 | - | $28.77 M(+22.9%) |
| Mar 2022 | - | $23.41 M(+28.5%) |
| Dec 2021 | $18.22 M(+49.6%) | $18.22 M(-4.1%) |
| Sep 2021 | - | $19.00 M(+22.8%) |
| Jun 2021 | - | $15.47 M(+27.0%) |
| Dec 2020 | $12.18 M(+35.7%) | $12.18 M |
| Dec 2019 | $8.97 M | - |
FAQ
- What is Enfusion annual accounts receivable?
- What is the all time high annual accounts receivable for Enfusion?
- What is Enfusion annual accounts receivable year-on-year change?
- What is Enfusion quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Enfusion?
- What is Enfusion quarterly accounts receivable year-on-year change?
What is Enfusion annual accounts receivable?
The current annual accounts receivable of ENFN is $28.07 M
What is the all time high annual accounts receivable for Enfusion?
Enfusion all-time high annual accounts receivable is $28.07 M
What is Enfusion annual accounts receivable year-on-year change?
Over the past year, ENFN annual accounts receivable has changed by +$2.21 M (+8.56%)
What is Enfusion quarterly accounts receivable?
The current quarterly accounts receivable of ENFN is $32.17 M
What is the all time high quarterly accounts receivable for Enfusion?
Enfusion all-time high quarterly accounts receivable is $33.67 M
What is Enfusion quarterly accounts receivable year-on-year change?
Over the past year, ENFN quarterly accounts receivable has changed by +$7.32 M (+29.44%)